Imbria Pharmaceuticals to Participate at SVB Leerink Biopharma Private Company Connect

Imbria Pharmaceuticals, Inc., a clinical stage, cardio-metabolic company developing novel therapies designed to enhance cellular energetics, today announced that Anne Prener, president and chief executive officer, Jai Patel, chief medical officer, and Komal Joshi, chief financial officer will participate in SVB Leerink’s Biopharma Private Company Connect, taking place virtually on March 29-31, 2022.

Contact:
Komal Joshi
Imbria Pharmaceuticals, Inc.
kjoshi@imbria.com